Display all Answers
OncoMed was incorporated in the state of Delaware in 2004.
OncoMed’s principal executive offices are located at 800 Chesapeake Drive, Redwood City, CA 94063. The telephone for this office is: (650) 995-8200
OncoMed's stock is traded on The NASDAQ Global Select Market under the symbol OMED. The company’s initial public offering (IPO) was on July 17, 2013
The underwriters for the IPO were Jefferies, Leerink Swann, Piper Jaffray and BMO Capital Markets.
The CUSIP number for OncoMed’s common stock is 68234X 10 2
Shares can be purchased through a stockbroker of your choice. OncoMed does not have a direct stock purchase plan.
We do not currently offer a dividend reinvestment program. We intend to retain all future earnings to finance the growth and development of our business and do not anticipate paying any cash dividends to our stockholders in the foreseeable future.
Computershare Trust Company, NA
250 Royall Street
Canton, Massachusetts 02021
US Phone: 1 800 962 4284
International Phone: 1 781 575 3120
If your shares are held in your name, you must contact our transfer agent, Computershare. If your shares are held in street name, you must contact your broker to update your address.
Our fiscal year ends December 31st.
Our legal counsel is:
Latham & Watkins, LLP
140 Scott Drive
Menlo Park, CA 94025
Our independent auditor is:
Ernst & Young LLP
275 Shoreline Drive, Ste. 600
Redwood City, CA 94065
Please submit your question using the form below. * Required fields